The vast majority of the patients who take statins don’t ever have to worry about the side effect of muscle symptoms. Even among those who do experience muscle damage, with […]
LEAP Rounds – Holiday 2021
Promotions
LEAP Rounds – Fall 2021
A prevalent belief among rheumatologists has been that an accurate diagnosis of Sjögren’s is not essential because of the lack of disease-modifying therapies. But a correct diagnosis is very important […]
LEAP Rounds – Spring 2020
Corticosteroids (prednisone) are the mainstay of therapy for systemic lupus erythematosus (SLE). Prednisone works: it has anti-inflammatory and immunosuppressive actions in SLE. This is why doctors who treat lupus patients […]
LEAP Rounds – Fall 2019
The first thing to remember is that everybody with a diagnosis of scleroderma is at risk of developing lung disease — either interstitial lung disease (ILD), which affects about 60 […]
Maintenance therapy in well-controlled vasculitis: Is it ever ok to stop?
“Whether or not” and “how” to taper off the last bit of medication for patients with clinically stable ANCA-associated vasculitis are hotly debated topics in the vasculitis field.
LEAP – Winter 2018 : Secret Messages : Decoding with Filters
For too long, doctors treating rheumatic diseases have had to base their management on instinct and experience.
The problem is that each physician has a limited experience – which means that many times we basically had to guess at how to treat a specific patient, using trial and error to find out what might work best.
